Navigation Links
Isis Reports Positive Phase 1 Data Demonstrating ISIS-APOCIIIRx Produces Significant Reductions in apoC-III Protein Levels and Triglycerides
Date:12/6/2011

CARLSBAD, Calif., Dec. 6, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive results from a Phase 1 study with ISIS-APOCIIIRx.  The results demonstrated that ISIS-APOCIIIRx treatment produced rapid, dose-dependent reductions of up to 78 percent in apolipoprotein C-III (apoC-III) protein and up to 44 percent in blood triglyceride levels.  In this study, the drug also demonstrated a good safety profile and was well tolerated.  These data will be presented today at the Cold Spring Harbor Laboratory 2nd RNA Therapeutics conference in New York.  

"Patients with high levels of triglycerides are at significant risk of cardiovascular disease even if LDL-cholesterol levels are within acceptable/normal levels.   High-risk patients, such as those with diabetes or metabolic syndrome, may also benefit from lowering their triglycerides.  Unfortunately the needs of these patients are not adequately met and new treatment options are needed," said Frank Sacks, M.D., Professor of Cardiovascular Disease Prevention, Harvard School of Public Health. "ApoC-III itself is a pro-inflammatory protein and a key atherogenic lipid particle.  In addition, recent data suggest that the inclusion of apoC-III in LDL particles increases their atherogenicity and therefore increases the risk of coronary artery disease.  The combined benefit of lowering both apoC-III and triglycerides could potentially exceed that observed with current therapies that only reduce triglycerides."

The Phase 1 study of ISIS-APOCIIIRx was a blinded, randomized, placebo-controlled, dose-escalation study designed to assess the safety and pharmacokinetic profile of ISIS-APOCIIIRx in healthy volunteers and to assess the initial effects of the drug on baseline apoC-III and triglyceride levels.  ISIS-APOCIIIRx was evaluated in sin
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Nov. 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... previously announced underwritten public offering of $50,000,000 of shares ... registration statement. The offering will consist of 49,751,244 shares ... $1.005 per share.  Lexicon has also granted the underwriters ... shares of common stock.  All of the shares in ...
(Date:11/18/2014)... MOUNT LAUREL, N.J. , Nov. 18, 2014 ... more than 230,000 American women this year who ... Manager Certification® today announced new resources for case ... cancer—stages 4 and 5—to navigate the myriad physical, ... territory. The resources are available at no cost ...
(Date:11/18/2014)... 18, 2014 SynCardia Systems, Inc., has been ... for Small Companies presented by the Arizona Technology Council ... The 11th annual Governor,s Celebration of Innovation Awards honor ... . Arizona Governor Jan ... SynCardia was honored for its Freedom® portable driver, which ...
Breaking Medicine Technology:Lexicon Announces Pricing Of Common Stock Offering 2Lexicon Announces Pricing Of Common Stock Offering 3New Breast Cancer Resources: Commission For Case Manager Certification Adds Specialty Tools to Case Management Body of Knowledge Online Learning Center 2SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 2SynCardia Named Innovator of the Year by the 2014 Governor's Celebration of Innovation Awards for Its Freedom Portable Driver 3
... GENR ) today reported data from its second ... candidate,for the treatment of type 2 diabetes and obesity. ... target that controls the function,of both the leptin and ... study, MSI-1436 was found to be well-tolerated and no,serious ...
... 60 percent of moderate to severe patients achieved ... remission at Week 10,in data from a 54-week ... (ACG) Annual Scientific Meeting, ORLANDO, Fla., Oct. ... prospective study investigating endoscopic improvement in Crohn,s,disease (CD) ...
Cached Medicine Technology:Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7
(Date:11/21/2014)... (PRWEB) November 21, 2014 For many busy ... multiple office visits and months of recovery from dental surgery ... – even at the cost of their youthful appearance. , ... Dental Art Institute in Oxnard and Woodland Hills, Calif., can ... one visit, even in instances where the patient’s bone has ...
(Date:11/21/2014)... 2014 Recently, TideStore.com, a leading online ... announced its special offer TideStore Thanksgiving Sales . ... TideStore.com are now provided with big discounts. The special ... can enjoy an extra 10% discount with this coupon ... addresses and have opportunities to win free gifts. TideStore.com ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 CARE Surrogacy ... its intended parents — and at the same time enhancing ... sense of optimism for future parents across the globe, the ... , Prospective parents today are zoning in on the skyrocketing ... the encumbering costs, are individuals over-stressing clinical success rates ...
(Date:11/21/2014)... November 21, 2014 First Choice ... 7am today. The new facility is located at 225 ... , “We are pleased to join the Friendswood ... emergency medical care here,” said Dr. Siddiqi, Facility Medical ... , To celebrate the opening, First Choice Emergency Room ...
(Date:11/21/2014)... HealthDay Reporter THURSDAY, Nov. 20, ... may help preserve thinking skills and memory as workers ... compared IQ scores obtained around age 11 from more ... scores around age 70. The scientists found that those ... thinking even years after retirement. Researchers from ...
Breaking Medicine News(10 mins):Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 2Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 3Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 4Health News:Anacapa Dental Art Institute Prosthodontists Develop New Technique to Offer Younger Appearance in Just One Visit 5Health News:Thanksgiving Sales from TideStore.com 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 3Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:Could Your Job Help Preserve Your Aging Brain? 2Health News:Could Your Job Help Preserve Your Aging Brain? 3
... HealthDay Reporter , WEDNESDAY, Dec. 14 (HealthDay News) ... may one day also prove useful in combating serious cases ... Journal of Infectious Diseases finds that patients hospitalized with ... a statin, compared with their peers who weren,t taking one ...
... TUESDAY, Dec. 13 (HealthDay News) -- In the aftermath of ... 38, the U.S. National Transportation Safety Board is recommending a ... electronic devices, except in emergencies. According to media reports, ... the fatal pileup that occurred last year in Gray Summit, ...
... (Boston) A study conducted by researchers at Boston ... exhaust particulates (DEP) and house dust extract (HDE) causes ... principle investigator Jiyoun Kim, PhD, professor of pathology, was ... Journal of Pathology and was selected by the ...
... This release is available in German . ... award in Germany have been announced: The Joint Committee of ... named eleven researchers two women and nine men ... by the relevant nominations committee from 131 nominations. Five of ...
... in German . Compared to Neanderthals, modern ... the temporal lobes and olfactory bulbs also suggest a combined ... The increase of brain size is intimately linked to the ... humans, have independently evolved brains of roughly the same size ...
... goats reveals the vastly different strategies of males in different ... hunting. A Durham University-led research team found that male ... different populations in order to succeed in the rut: some ... while others wait until they are much older. Researchers ...
Cached Medicine News:Health News:Could Statins Help Those Hospitalized With Flu? 2Health News:U.S. Safety Board Urges Nationwide Ban on Drivers' Use of Cellphones 2Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 2Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 3Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 4Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 5Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 6Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 7Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 8Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 9Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 10Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 11Health News:Leibniz Prize 2012 to honor 11 outstanding researchers 12Health News:Follow your nose 2Health News:Complex sex life of goats could have implications for wildlife management 2Health News:Complex sex life of goats could have implications for wildlife management 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: